Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Vaccine against autoimmune disease: can helminths or their products provide a therapy?
Botulinum Toxin-What Urologic Uses Does the Data Support?
Fingolimod for the treatment of relapsing multiple sclerosis.
Myelin proteomics: the past, the unexpected and the future.
Statins in neurological disorders: An overview and update.
Synaptic signal streams generated by ex vivo neuronal networks contain non-random, complex patterns.
TNF-α-mediated anxiety in a mouse model of multiple sclerosis.
Multi-Sectional Views Textural Based SVM for MS Lesion Segmentation in Multi-Channels MRIs.
Epidemiology of environmental exposures and human autoimmune diseases: Findings from a National Institute of Environmental Health Sciences Expert Panel Workshop.
Are ERM (ezrin/radixin/moesin) proteins targets for autoantibodies in demyelinating neuropathies?
Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments.
The Blood-Brain Barrier in Multiple Sclerosis: MicroRNAs as Key Regulators.
MRI relaxation in the presence of fictitious fields correlates with myelin content in normal rat brain.
[Chronic inflammatory demyelinating polyradiculoneuropathy revealing essential thrombocythemia].
A Swiss real world best practice experience in three different clinical settings of the 6 hour fingolimod first dose observation procedure.
Mechanisms of cell-cell interaction in oligodendrogenesis and remyelination after stroke.
Diffusion tensor magnetic resonance imaging in very early onset pediatric multiple sclerosis.
[Pathogenesis of chronic inflammatory demyelinating polyneuropathy].
Health-related quality of life in multiple sclerosis patients with bladder, bowel and sexual dysfunction.
Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study.
Intraoperative smile in a multiple sclerosis patient with medication-refractory tremor.
Consequences of perinatal bisphenol A exposure in a mouse model of multiple sclerosis.
Burden of disease in multiple sclerosis patients with spasticity in Germany: mobility improvement study (Move I).
Treatment of Experimental Autoimmune Encephalomyelitis by Co-Delivery of Disease Associated Peptide and Dexamethasone in Acetalated Dextran Microparticles.
Structural and Functional Abnormalities of the Neuromuscular Junction in the Trembler-J Homozygote Mouse Model of Congenital Hypomyelinating Neuropathy.
Pages
« first
‹ previous
…
446
447
448
449
450
451
452
453
454
…
next ›
last »